No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antineoplastic Agents / adverse effects*
-
CTLA-4 Antigen / genetics*
-
Diabetes Mellitus, Type 1 / chemically induced*
-
Diabetes Mellitus, Type 1 / genetics
-
Female
-
HLA Antigens / genetics*
-
Humans
-
Melanoma / drug therapy
-
Melanoma / secondary
-
Middle Aged
-
Nivolumab
-
Organ Size / genetics
-
Pancreas / pathology*
-
Polymorphism, Genetic
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / pathology
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
CTLA-4 Antigen
-
HLA Antigens
-
Nivolumab